PI3K pathway activation also differed based on IDH status: upstream changes such as PTEN deletion or AKT gain were more common in IDHwt gliomas and MTOR gain was significantly less common (p = 2 × 10−7, 0.002, and 1 × 10−5, respectively). This evidence concerns the gene IDH2 and central nervous system cancer.